165 related articles for article (PubMed ID: 31853790)
1. Assessment of increased glomerular permeability associated with recurrent focal segmental glomerulosclerosis using an in vitro model of the glomerular filtration barrier.
Li M; Alfieri CM; Morello W; Cellesi F; Armelloni S; Mattinzoli D; Montini G; Messa P
J Nephrol; 2020 Aug; 33(4):747-755. PubMed ID: 31853790
[TBL] [Abstract][Full Text] [Related]
2. Pathobiology of focal segmental glomerulosclerosis: new developments.
D'Agati VD
Curr Opin Nephrol Hypertens; 2012 May; 21(3):243-50. PubMed ID: 22357339
[TBL] [Abstract][Full Text] [Related]
3. Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.
Shoji J; Mii A; Terasaki M; Shimizu A
Nephron; 2020; 144 Suppl 1():65-70. PubMed ID: 33260184
[TBL] [Abstract][Full Text] [Related]
4. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
Schwartz MM
Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
[TBL] [Abstract][Full Text] [Related]
5. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
6. Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis.
Kachurina N; Chung CF; Benderoff E; Babayeva S; Bitzan M; Goodyer P; Kitzler T; Matar D; Cybulsky AV; Alachkar N; Torban E
Am J Physiol Renal Physiol; 2016 May; 310(10):F1148-56. PubMed ID: 26719363
[TBL] [Abstract][Full Text] [Related]
7. Novel in vitro assays to detect circulating permeability factor(s) in idiopathic focal segmental glomerulosclerosis.
den Braanker DJW; Maas RJ; Deegens JK; Yanginlar C; Wetzels JFM; van der Vlag J; Nijenhuis T
Nephrol Dial Transplant; 2021 Jan; 36(2):247-256. PubMed ID: 33155059
[TBL] [Abstract][Full Text] [Related]
8. Permeability factors in focal and segmental glomerulosclerosis.
Reiser J; Nast CC; Alachkar N
Adv Chronic Kidney Dis; 2014 Sep; 21(5):417-21. PubMed ID: 25168830
[TBL] [Abstract][Full Text] [Related]
9. Characterizing Glomerular Barrier Dysfunction with Patient-Derived Serum in Glomerulus-on-a-Chip Models: Unveiling New Insights into Glomerulonephritis.
Kim SY; Choi YY; Kwon EJ; Seo S; Kim WY; Park SH; Park S; Chin HJ; Na KY; Kim S
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791159
[TBL] [Abstract][Full Text] [Related]
10. Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.
Sharma M; Zhou J; Gauchat JF; Sharma R; McCarthy ET; Srivastava T; Savin VJ
Transl Res; 2015 Oct; 166(4):384-98. PubMed ID: 25843671
[TBL] [Abstract][Full Text] [Related]
11. Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis.
Müller-Deile J; Sarau G; Kotb AM; Jaremenko C; Rolle-Kampczyk UE; Daniel C; Kalkhof S; Christiansen SH; Schiffer M
Sci Rep; 2021 Feb; 11(1):4577. PubMed ID: 33633212
[TBL] [Abstract][Full Text] [Related]
12. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients.
Srivastava P; Solanki AK; Arif E; Wolf BJ; Janech MG; Budisavljevic MN; Kwon SH; Nihalani D
Kidney Int; 2019 Mar; 95(3):708-716. PubMed ID: 30709661
[TBL] [Abstract][Full Text] [Related]
14. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
15. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E
PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586
[TBL] [Abstract][Full Text] [Related]
17. OPN deficiency results in severe glomerulosclerosis in uninephrectomized mice.
Schordan S; Grisk O; Schordan E; Miehe B; Rumpel E; Endlich K; Giebel J; Endlich N
Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1458-70. PubMed ID: 23552865
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the determinants of the glomerular filtration barrier: what goes round must come round.
Schlöndorff D; Wyatt CM; Campbell KN
Kidney Int; 2017 Sep; 92(3):533-536. PubMed ID: 28807257
[TBL] [Abstract][Full Text] [Related]
19. Focal segmental glomerulosclerosis; why does it occur segmentally?
Nagata M; Kobayashi N; Hara S
Pflugers Arch; 2017 Aug; 469(7-8):983-988. PubMed ID: 28664408
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional podocyte-endothelial cell co-cultures: Assembly, validation, and application to drug testing and intercellular signaling studies.
Li M; Corbelli A; Watanabe S; Armelloni S; Ikehata M; Parazzi V; Pignatari C; Giardino L; Mattinzoli D; Lazzari L; Puliti A; Cellesi F; Zennaro C; Messa P; Rastaldi MP
Eur J Pharm Sci; 2016 Apr; 86():1-12. PubMed ID: 26924225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]